Has Robin Reed received payments from drug or device companies?

Yes. Drug and device makers reported $3,649 in general payments to Robin Reed across 258 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robin Reed did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robin Reed come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robin Reed

Pediatrics · Grove City, OHNPI 1043436322

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 258 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Corium, LLC at 26.8% of the total. Reporting peaked in 2022 at $2,046 and has fallen 97.2% since, to $57 in 2024. Among pediatrics clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,649in general payments, 2019–2025

Across 258 payments — averaging $14.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Corium, LLC$978
Tris Pharma Inc$615
Supernus Pharmaceuticals, Inc.$582
Neos Therapeutics, LP$414
Takeda Pharmaceuticals U.S.A., Inc.$316
Ironshore Pharmaceuticals Inc.$238
plus $505 from 13 others

What the payments were for

Food & beverage$3,649100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Corium, LLC	75	$978
Tris Pharma Inc	46	$615
Supernus Pharmaceuticals, Inc.	37	$582
Neos Therapeutics, LP	43	$414
Takeda Pharmaceuticals U.S.A., Inc.	17	$316
Ironshore Pharmaceuticals Inc.	9	$238
Merck	6	$90
Cognoa, Inc.	4	$77
Adlon Therapeutics L.p.	4	$69
GSK	3	$52
Sanofi Pasteur Inc.	3	$48
Phadia US Inc.	2	$37
Pfizer	2	$36
Seqirus USA Inc	2	$32
Sobi, Inc	1	$17
Alfasigma USA, Inc.	1	$15
Kaleo, Inc.	1	$12
AstraZeneca	1	$12
Aytu Biopharma, Inc.	1	$8

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,649 in reported general payments places this provider in the 95th percentile of 2,041 pediatrics providers in Ohio.

See all pediatrics providers in Ohio →

Other pediatrics in Grove City

Jon DvorakPerrysburg$212K
Charles DebrosseCincinnati$135K
Scott WexelblattCincinnati$64K
Breanne RocheSolon$58K
Richard BreenHilliard$43K
Catherine McDanielDayton$34K
Lisa RichardsToledo$31K
Kristie RossCleveland$20K
Jessica CastonguayAkron$18K
Ryan SummersCleveland$15K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →